Single-use Bioprocessing Probes and Sensors Market: Real-Time Process Monitoring and Biopharma Expansion Drive Rapid Growth
The global Single-use Bioprocessing Probes and Sensors Market is entering a high-growth phase as biopharmaceutical manufacturers increasingly adopt disposable technologies, automated process monitoring, and real-time analytics. According to Maximize Market Research, the market was valued at USD 4,214.34 million in 2025 and is expected to reach nearly USD 13,704.82 million by 2034, expanding at a CAGR of 14% from 2026 to 2034. Single-use probes and sensors enable biopharmaceutical manufacturers to monitor critical process parameters such as pH, dissolved oxygen, temperature, pressure, conductivity, flow, and viable cell density while reducing contamination risks and the need for conventional cleaning and sterilization procedures. The increasing use of single-use bioreactors, cell and gene therapy manufacturing, and flexible biomanufacturing facilities is creating strong demand for integrated monitoring solutions.
* Explore Investment Opportunities: https://www.maximizemarketresearch.com/request-sample/114915/
Market Estimation, Growth Drivers and Opportunities
The growing adoption of disposable bioprocessing technologies is the central factor accelerating the market. Biopharmaceutical manufacturers increasingly require continuous monitoring of critical process parameters to improve product quality, process consistency, and manufacturing efficiency. Single-use sensors can be integrated directly into disposable bags and bioreactors, allowing measurements without interrupting production. The MMR report highlights strong demand for disposable probes and sensors among biopharmaceutical companies, supported by the modernization of disposable bioreactors and broader adoption of one-time-use systems.
The expansion of biologics, vaccines, monoclonal antibodies, cell therapies, and gene therapies is creating further opportunities. Manufacturers are also moving toward automated and data-driven production environments, increasing demand for sensors capable of delivering real-time information for process control. Innovations in optical dissolved-oxygen sensing, viable-cell-density measurement, conductivity monitoring, integrated pH sensing, and digital connectivity can improve automation and reduce manual sampling. Hamilton, for example, offers pre-calibrated and gamma-sterilized single-use sensors that integrate with existing bioreactor controllers, while its Incyte-P SU technology enables real-time viable-cell-density measurement.
U.S. Market Trends and Investment
The United States remains a major center for single-use bioprocessing because of its large biopharmaceutical manufacturing base, advanced research infrastructure, and strong investment in biologics production. A major development in 2025 was Thermo Fisher Scientific's announcement of an additional $2 billion investment in U.S. operations over four years, including $1.5 billion in capital expenditures to expand and enhance American manufacturing capacity. The company also agreed in February 2025 to acquire Solventum's Purification & Filtration business for approximately $4.1 billion, strengthening its bioprocessing portfolio and expanding capabilities across upstream and downstream workflows. Thermo Fisher's 2025 work on enhanced single-use fermentors also demonstrates the industry's movement toward scalable systems that improve oxygen transfer and process performance. These investments are expected to strengthen the U.S. biomanufacturing ecosystem and support demand for integrated single-use monitoring technologies.
Market Segmentation: Largest-Share Segments
By Sensor Type, the pH Sensor segment dominated the market with a 21.2% revenue share in 2025. pH is one of the most closely monitored physiochemical parameters in bioprocessing, making reliable pH measurement essential for maintaining cell growth, product quality, and process stability. Technological developments such as pH sensors incorporating temperature measurement are further supporting segment growth. The increasing use of single-use pH sensors in disposable bioreactors and bags provides manufacturers with ready-to-use monitoring while minimizing contamination and sterilization requirements.
By Workflow, the Upstream segment held the dominant position, accounting for a 71.2% revenue share in 2022 according to the MMR report. The segment benefits from the widespread adoption of disposable bioreactors and single-use media bags in upstream manufacturing. Monitoring pH, dissolved oxygen, cell viability, nutrient levels, temperature, and cell density is critical during cell culture and fermentation, making sensor integration particularly important in upstream operations.
By Application, the Biopharmaceutical Manufacturer segment dominated with a 61.2% market share in 2025. The segment's leadership reflects the broad application of disposable sensors in commercial and clinical biopharmaceutical manufacturing and continued product development by equipment and sensor suppliers.
Single-use Bioprocessing Probes and Sensors Market, Key Players are
Sartorius AG
Danaher Corporation
Thermo Fisher Scientific Inc.
Cytiva
Hamilton Company
PreSens Precision Sensing GmbH
PendoTECH LLC
Broadley-James Corporation
Parker Hannifin Corporation
Malema Engineering Corporation
ABEC
Mettler-Toledo International Inc.
Emerson Electric Co.
High Purity New England, Inc.
ESI Ultrapure
Competitive Analysis
The MMR report identifies Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., Cytiva, and Hamilton Company among the key companies in the global market. The supplied report does not disclose individual revenue-share percentages for these five companies, so unsupported company-specific market-share figures are not assigned.
Sartorius AG continued investing in bioprocessing infrastructure during 2025. Its French Aubagne site expansion nearly doubled cleanroom capacity and added automated production lines for 2D and 3D single-use bags, while renewable raw materials and automated logistics were incorporated into the expanded facility. Sartorius also partnered with Tulip in 2025 to advance digital transformation in single-use bioprocessing, combining process equipment with digital manufacturing applications.
Danaher Corporation, through its bioprocessing businesses including Cytiva and Pall, benefits from growing demand for integrated single-use manufacturing and process analytics. Cytiva's solutions combine single-use equipment with in-line sensing and automated process control, enabling real-time monitoring of variables such as viable cell density and process pressure.
Thermo Fisher Scientific strengthened its bioprocessing position through its 2025 acquisition of Solventum's Purification & Filtration business. The transaction expanded Thermo Fisher's capabilities in filtration and separation while complementing its existing single-use bioprocessing portfolio. Its DynaDrive and HyPerforma platforms also support scalable single-use manufacturing from development through production.
Cytiva continues to focus on integrated single-use manufacturing platforms and real-time process control. Its FlexFactory approach combines single-use equipment, automation, and monitoring technologies, while in-line sensors can support automated feedback loops and continuous process monitoring.
Hamilton Company is strengthening the sensor segment through technologies such as OneFerm pH sensors, optical dissolved-oxygen sensors, conductivity sensors, and Incyte solutions for viable-cell-density measurement. Its pre-calibrated and gamma-sterilized sensor technologies are designed for direct integration into single-use bags and bioreactors.
Regional Analysis
United States: North America dominated the market with a 35% share in 2025, supported by major biopharmaceutical manufacturers, strong sensor adoption, advanced research infrastructure, and the presence of leading companies such as Thermo Fisher and Hamilton.
Germany: Germany benefits from its strong biotechnology and pharmaceutical manufacturing ecosystem and the presence of Sartorius, supporting innovation in single-use technologies and process analytics.
France: France is becoming an important manufacturing and R&D location. Sartorius' expanded Aubagne facility demonstrates continued investment in single-use bioprocessing infrastructure and manufacturing capacity.
United Kingdom: The UK offers opportunities through its established life-sciences sector, pharmaceutical research base, and growing adoption of flexible biomanufacturing technologies.
Japan: Japan's advanced pharmaceutical industry and increasing demand for flexible biomanufacturing create opportunities for single-use systems. Cytiva's FlexFactory technologies have also been selected for biomanufacturing infrastructure supporting mRNA and monoclonal-antibody production in Japan.
China: China's expanding biologics manufacturing capacity, growing pharmaceutical pipeline, and increasing investment in modern production technologies create substantial long-term demand for single-use probes, sensors, and automated process-monitoring systems.
Related Reports
Neonatal respiratory distress syndrome treatment Market https://www.maximizemarketresearch.com/market-report/neonatal-respiratory-distress-syndrome-treatment-market/211019/
mRNA vaccines Market https://www.maximizemarketresearch.com/market-report/mrna-vaccines-market/213483/
Menstrual Cup Market https://www.maximizemarketresearch.com/market-report/menstrual-cup-market/213519/
Conclusion
The Single-use Bioprocessing Probes and Sensors Market is positioned for rapid expansion as biopharmaceutical manufacturing shifts toward flexible, automated, contamination-controlled, and data-driven production. The increase from USD 4.21 billion in 2025 to nearly USD 13.70 billion by 2034 highlights the scale of the opportunity. In my view, the strongest growth factor will be the integration of single-use sensors with automation, real-time analytics, and advanced process control. Sensor technologies capable of continuously monitoring pH, dissolved oxygen, viable cell density, conductivity, pressure, and other critical parameters can help manufacturers improve productivity while reducing manual intervention. The combination of biologics growth, cell and gene therapy manufacturing, process intensification, and demand for faster facility turnaround will create significant opportunities for sensor manufacturers and integrated bioprocessing technology providers.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 [email protected]